01 1Ash Stevens LLC
02 1Glenmark Life Sciences Limited
03 1Maithri Drugs Private Limited
01 3Lomitapide Mesylate
01 2India
02 1U.S.A
NDC Package Code : 48957-0086
Start Marketing Date : 2016-07-11
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 66039-923
Start Marketing Date : 2016-03-22
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 70600-005
Start Marketing Date : 2021-12-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A Lomitapide Mesylate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Lomitapide Mesylate, including repackagers and relabelers. The FDA regulates Lomitapide Mesylate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Lomitapide Mesylate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Lomitapide Mesylate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Lomitapide Mesylate supplier is an individual or a company that provides Lomitapide Mesylate active pharmaceutical ingredient (API) or Lomitapide Mesylate finished formulations upon request. The Lomitapide Mesylate suppliers may include Lomitapide Mesylate API manufacturers, exporters, distributors and traders.
click here to find a list of Lomitapide Mesylate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Lomitapide Mesylate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Lomitapide Mesylate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Lomitapide Mesylate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Lomitapide Mesylate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Lomitapide Mesylate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Lomitapide Mesylate suppliers with NDC on PharmaCompass.
We have 3 companies offering Lomitapide Mesylate
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
